IBRO Neuroscience Reports (Oct 2023)
NOVEL COMPOUNDS TARGETING SYNAPSIN III RESCUE ALPHA-SYNUCLEIN AGGREGATION AND NIGROSTRIATAL DYSFUNCTION AND DEGENERATION IN EXPERIMENTAL MODELS OF PARKINSON’S DISEASE
- Francesca Longhena,
- Gaia Faustini,
- Andrea Casiraghi,
- Valentina Straniero,
- Giovanni Ribaudo,
- Veronica Mutti,
- Gisela Camacho-Hernandez,
- Cristina Missale,
- Amy Hauck Newman,
- Federica Bono,
- Alessandra Gianoncelli,
- Ermanno Valoti,
- Arianna Bellucci
Affiliations
- Francesca Longhena
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Gaia Faustini
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Andrea Casiraghi
- University of Milan, Department Of Pharmaceutical Sciences, Milan, Italy
- Valentina Straniero
- University of Milan, Department Of Pharmaceutical Sciences, Milan, Italy
- Giovanni Ribaudo
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Veronica Mutti
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Gisela Camacho-Hernandez
- NIDA-IRP, Medicinal Chemistry Section, Molecular Targets And Medications Discovery Branch, Baltimore, United States of America
- Cristina Missale
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Amy Hauck Newman
- NIDA-IRP, Medicinal Chemistry Section, Molecular Targets And Medications Discovery Branch, Baltimore, United States of America
- Federica Bono
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Alessandra Gianoncelli
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Ermanno Valoti
- University of Milan, Department Of Pharmaceutical Sciences, Milan, Italy
- Arianna Bellucci
- University of Brescia, Department Of Molecular And Translational Medicine, Brescia, Italy
- Journal volume & issue
-
Vol. 15
p. S441